Loading...

XWEL XWELL INC Contract Awards 8-K Filing

XWLL

XWL

XWELL INC

(XWEL)

2025 8-K

Private Placement Completed

Private Placement Agreement

Annual Meeting Results

Delisting Notice

Financial Results Update

Equity Modification

Annual Meeting Notice

Financial Restructuring

Annual Meeting Update

Annual Meeting Postponed

Financial Results Update

Compliance with Listing Rules

Bylaw Amendments

Financial Statements

Accounting Firm Change

Financial Results

Incentive Plan Update

Strategic Investment

Contract Extension

Management Changes

Stockholder Update

Financial Results

Annual Meeting Results

Management Changes

Tax Benefits Plan

Financial Results

Securities Purchase Agreement

Bylaws Amendment

Results of Operations and F...

Results of Operations and F...

Accounting Misapplication

Late Filing Notification

Expansion of Bio-Surveillan...

Appointment of Directors

Management Changes

Results of Operations and F...

Compliance Regained

Investor Fireside Chat

Amendment for Reverse Split

Acquisition Announcement

Earnings Reports

Appointment of CFO

Departure of Directors or C...

Results of Operations and F...

Appointment of CFO

Delisting Notice

Earnings Reports

Late Filing and Preliminary...

External Links:

On March 5, 2025, XWELL, Inc. announced the extension of its Traveler-based Genomic Surveillance program with the CDC for three more years.

AI Assistant

XWELL INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.